See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $398B | 4.7x | 17.1x | |
| $397B | 6.9x | 15.3x | |
| $242B | 4.9x | 20.6x | |
| $178B | 2.6x | 12.5x | |
| $78.4B | 3.9x | 15.8x | |
| $63.6B | 8.6x | 37.5x | |
| $63.3B | 1.2x | 5.7x | |
| $58.0B | 3.9x | 15.4x | |
| $54.3B | 2.9x | 10.1x | |
| $53.2B | 3.4x | 14.6x | |
| $51.2B | 2.6x | 12.7x | |
| $48.6B | 5.4x | 22.3x | |
| $32.4B | 1.3x | 7.5x | |
| $30.3B | 2.1x | 15.2x | |
| $30.3B | 6.3x | 27.4x | |
| $27.9B | 2.5x | 14.3x | |
| $24.3B | 4.0x | 17.3x | |
| $22.3B | 1.5x | 8.2x | |
| $22.1B | 2.2x | 6.5x | |
| $20.2B | 1.8x | 12.2x | |
| $19.8B | 1.7x | 11.1x | |
| $15.2B | 8.9x | 42.5x | |
| $12.3B | 2.2x | 15.7x | |
| $12.2B | 1.8x | 9.5x | |
| $11.8B | 8.0x | 30.4x | |
| $11.8B | 2.1x | 10.7x | |
| $10.8B | 8.4x | 42.5x | |
| $10.0B | 11.8x | 27.3x | |
| $9.6B | 6.5x | 34.9x | |
| $8.5B | 1.3x | 12.0x | |
| $8.4B | 1.4x | 7.7x | |
| $8.1B | 11.2x | 34.6x | |
| $6.8B | 1.6x | 9.2x | |
| $6.0B | 2.3x | 10.3x | |
| $5.3B | 11.9x | 39.0x | |
| $5.2B | 4.6x | 14.0x | |
| $5.2B | 10.0x | 40.6x | |
| $5.2B | 1.8x | 13.3x | |
| $4.9B | 3.1x | 16.7x | |
| $4.6B | 3.5x | 15.9x | |
| $4.6B | 1.3x | 7.5x | |
| $4.2B | 2.0x | 13.5x | |
| $4.0B | 2.7x | 13.3x | |
| $3.6B | 1.7x | 9.6x | |
| $3.6B | 3.5x | 23.6x | |
| $3.2B | 4.6x | 20.8x | |
| $3.2B | 3.1x | 14.1x | |
| $3.1B | 1.0x | 5.9x | |
| $3.1B | 0.6x | 5.7x | |
| $3.1B | 6.9x | 25.0x | |
| $3.0B | 0.6x | 5.9x | |
| $3.0B | 8.9x | 35.7x | |
| $2.9B | 4.7x | 23.0x | |
| $2.7B | 1.2x | 7.8x | |
| $2.6B | 1.2x | 10.4x | |
| $2.5B | 0.9x | 7.5x | |
| $2.5B | 1.0x | 5.1x | |
| $2.3B | 0.7x | 4.9x | |
| $2.2B | 1.9x | -61.5x | |
| $2.2B | 2.7x | 17.8x | |
| $2.1B | 1.1x | 9.4x | |
| $2.0B | 3.4x | 20.5x | |
| $1.9B | 1.2x | 10.1x | |
| $1.8B | 4.6x | 13.0x | |
| $1.8B | 3.2x | 15.6x | |
| $1.7B | 0.9x | 6.0x | |
| $1.6B | 0.7x | 7.8x | |
| $1.5B | 1.3x | 9.3x | |
| $1.4B | 1.9x | 10.4x | |
| $1.4B | 1.2x | 9.6x | |
| $1.4B | 0.7x | 5.8x | |
| $1.4B | 2.5x | 9.8x | |
| $1.4B | 4.8x | 11.0x | |
| $1.1B | 1.6x | 6.3x | |
| $1.0B | 1.5x | 10.7x | |
| $956M | 7.1x | 26.7x | |
| $921M | 2.2x | 8.0x | |
| $908M | 3.7x | 108.7x | |
| $755M | n/a | n/a | |
| $731M | n/a | n/a | |
| $715M | 2.4x | -238.0x | |
| $679M | 1.5x | 7.1x | |
| $631M | 0.9x | 6.5x | |
| $605M | 0.9x | 4.5x | |
| $592M | 0.2x | 1.5x | |
| $549M | 2.2x | 9.3x | |
| $539M | 1.9x | 12.0x | |
| $512M | 1.3x | 19.0x | |
| $501M | 0.4x | 4.8x | |
| $454M | 0.3x | n/a | |
| $454M | 3.1x | 12.3x | |
| $450M | n/a | n/a | |
| $448M | 2.2x | -30.8x | |
| $380M | 1.2x | 25.2x | |
| $378M | 1.6x | 18.1x | |
| $376M | 1.0x | 6.5x | |
| $374M | n/a | n/a | |
| $362M | n/a | n/a | |
| $320M | n/a | n/a | |
| $309M | n/a | n/a | |
| $301M | n/a | n/a | |
| $297M | 0.8x | 9.1x | |
| $256M | 5.4x | 20.0x | |
| $231M | 1.2x | 7.3x | |
| $205M | 0.4x | 9.8x | |
| $180M | n/a | n/a | |
| $179M | 0.9x | 9.5x | |
| $177M | 0.6x | 7.3x | |
| $157M | 2.4x | 10.9x | |
| $144M | 0.6x | 6.4x | |
| $140M | 2.4x | 7.6x | |
| $118M | n/a | n/a | |
| $103M | n/a | n/a | |
| $40.5M | 1.6x | 6.7x | |
| $36.4M | n/a | n/a | |
| $31.7M | 0.7x | 4.9x | |
| $28.7M | n/a | n/a | |
| $27.6M | n/a | n/a | |
| $22.3M | 1.7x | n/a | |
| $20.4M | 0.9x | -80.5x | |
| $18.2M | n/a | n/a | |
| $17.1M | n/a | n/a | |
| $10.8M | n/a | n/a | |
| $5.8M | n/a | n/a | |
| $0.7M | n/a | n/a | |
| $0.6M | n/a | n/a | |
| -$10.2M | -0.0x | -0.4x | |
| -$24.4M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty